Live lymphoma updates

Live lymphoma news coverage of developments with the latest updates. Stay on top of latest lymphoma news stories and find out what just happened, what is going on with lymphoma. The latest real-time news updates and headlines on lymphoma
Sam Neill’s Rare Lymphoma: Clinical Trials Show Promise
CAR T Cells Show Promising Results in Myeloma Trial
Insights into Cellular Bridges Illuminate Development, Disease
Insights on Cellular Bridges Reveal Development, Disease Clues
AFGSC Commander OKs Formal Probe Into Missile Cancer Worries
LOWVELO Riders Raise $427k for Hollings Cancer Research
Australian Blood Cancer Patients Face Unaffordable Costs
Regional Blood Cancer Patients Struggle with High Costs in Australia
Research Links Enzymes to Proteins in Cells
CD74 Targeted in B-Cell Non-Hodgkin Lymphoma with STRO-001
Drug Improves Progression-Free Survival in CLL Patients
Oncotarget | Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell
Magic traditional Chinese medicine ingredients generated autophagic flux to suppress tumor progression and novel combination therapy
Experimental monoclonal antibodies show promise against Epstein-Barr virus
Response-adapted ultra-low dose radiation achieves complete response
Bcl10 phosphorylation-dependent droplet-like condensation positively regulates DNA virus-induced innate immune signaling
Friendship with heart leads to BIG LUNCH event in Brisbane
Family ties: Inherited genetic variants increase risk of Hodgkin lymphoma
Inherited genetic variants increase risk of Hodgkin lymphoma
Emotional connection to Legacy Week
New CAR-T technology brings hope to patients of refractory and relapsed lymphoma
Simple blood test predicts neurotoxic complications of CAR-T cell therapy
FSU biologists discover how cancer-causing virus avoids triggering immune system response
Eighth annual Crush Challenge bike ride to accelerate cancer research on Aug. 27
Getting more mileage from T-cell therapy for AML
Stanford cancer team halts growth of multiple myeloma and diffuse large B cell lymphoma with custom molecule sBCMA-Fc V3
FDA Approves Drug for Rare Cancer
People with early-stage Hodgkin lymphoma face higher risk of dying from cardiovascular disease than from cancer
Strengthening immune response to cancer
Medicine: Hopkins story
With radically improved pain control, bone marrow donors can gift stem cells without worry of undue side effects or opioid use
Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma
Towards cure for lymphoma: new research brings hope
Use of short-course radiation therapy for lymphomas
Arkansas State Rep. Dwight Tosh honored at St. Jude for 60-year survival of childhood cancer
New mechanism in CD47 blockade treatment in HCC
Interferon gamma receptor pathway is necessary for CAR T-cell mediated killing in solid tumors
AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases
How social work researcher’s experience with young adult cancer informed his work
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma
Researchers discover new tools in regular blood samples for developing precision therapies for lymphoma
Simple way to study mouse epigenome
Patient helps others while participating in Hollings’ clinical trial for multiple myeloma
New research highlights clinical importance of interaction between immune cells in lymphoma microenvironment
Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer’s
Researchers Identify New Therapeutic Target for Hematologic Malignancies
MD Anderson and Yingli Pharma initiate strategic collaboration to advance development of multiple oncology programs
MSK Chief of Lymphoma Service Gilles Salles Presents Promising New Treatment for Patients with Diffuse Large B-Cell Lymphoma